Lenabasum Studied for Refractory Cutaneous Dermatomyositis

TUESDAY, Oct. 11, 2022 -- Lenabasum is well tolerated for the treatment of amyopathic dermatomyositis, according to a phase 2 study published online Oct. 1 in the Journal of Investigative Dermatology.
Victoria P. Werth, M.D., from the University of...